Nucleic acid targeting: Therapeutic strategies for the 21st century

British Journal of Cancer

Volumn 80, Issue SUPPL. 1, 1999, Pages 65-85

  Thurston, D E ^a  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; ANTINEOPLASTIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; BCR ABL PROTEIN; CGP 69846A; CHLORMETHINE; CHROMOMYCIN; CISPLATIN; COMPLEMENTARY RNA; CONGOCIDINE; DACARBAZINE; DISTAMYCIN A; DOXORUBICIN; FOMIVIRSEN; GEMO 231; GENE EXPRESSION MODULATOR 132; ISIS 2503; ISIS 3521; LEXITROPSIN; MITOMYCIN; OBLIMERSEN; RACHELMYCIN; RETICULOSE; RIBOZYME; TEMOZOLOMIDE; TRABECTEDIN; TRANSCRIPTION FACTOR; TRECOVIRSEN; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINC FINGER PROTEIN;

ANIMAL CELL; CANCER CHEMOTHERAPY; CANCER RESEARCH; CONFERENCE PAPER; DRUG DNA BINDING; DRUG STRUCTURE; DRUG TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BASE SEQUENCE; DNA; FORECASTING; GENE TARGETING; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES, ANTISENSE; RNA;

EID: 0032797401     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (114)

1. Akhtar S (1998) Antisense technology: selection and delivery of optimally acting antisense oligonucleotides. J Drug Targeting 5: 225-234
2. Akhtar S and Agrawal S (1997) In vivo studies with antisense oligonucleotides. Trends Pharmacol Sci 18: 12-18
3. Akhtar S and Lewis KJ (1997) Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres. Int J Pharmaceut 151: 57-67
4. Amsterdam A and Selvaraj N (1997) Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes. Endocr Rev 18: 435-461
5. Armilage B, Koch T, Frydenlund H, Orum H and Schuster GB (1998) Peptide nucleic acid (PNA) DNA hybrid duplexes; interealation by an internally linked anthraquinone. Nucleic Acids Res 26: 715-720
6. Asselme U, Thoung NT and Helene C (1997) Synthesis and properties of oligonucleotides covalently linked to interealating agents. New J Chem 21: 5-17
7. Behrens C and Nielsen PE (1998) A combinatorial approach to new DNA minor groove binders. Combin Chem High Throughpm Screen 1: 127-134
8. Bichenkova EV, SadatEbrahimi SE, Wilton AN, Otoole N, Marks DS and Douglas KT (1998) Strong, specific, reversible binding ligands for transfer RNA: comparison by fluorescence and NMR spectroscopies with distamycin binding for a new structural class of ligand. Nucleosides Nucleotides 17: 1651-1665
9. Boger DL and Turnbull P (1998) Synthesis and evaluation of a carbocyclic analogue of the CC 1065 and duocarmycin alkylation subunits: role of the vinylogous amide and implications on DNA alkylation catalysis. J Organic Chem 63: 8004-8011
10. Bonham MA, Brown S, Boyd AL, Brown PH, Bruckenstein DA, Hanvey JC, Thomson SA. Pipe A, Hassman F, Bisi JE, Froehler BC, Matteucci MD, Wagner RW, Noble SA and Babiss LE (1995) An assessment of the antisense properties of RNase H-competent and sterie-blocking oligomers. Nucleic Acids Res 23: 1197-1203
11. Bose DS, Thompson AS, Ching JS, Hartley JA, Berardini MD, Jenkins TC, Neidle S, Hurley LH and Thurston DE (1992a) Rational design of a highly efficient irreversible DNA interstrand cross-linking agent based on the pyrrolobenzodiazepine ring system. J Am Chem Soc 114: 4939-4941
12. Bose DS, Thompson AS, Smellie M, Berardini MD, Hartley JA, Jenkins TC, Neidle S and Thurston DE (1992b) Effect of linker length on DNA-binding affinity, cross linking efficiency and cytotoxicity of C8-linked pyrrolobenzodiazepine dimers. J Chem Soc Chem Commun 1518-1520
13. Brown PM and Fox KR (1996) Nueleosome core particles inhibit DNA triple helix formation. Biochem J 319: 607-611
14. Browne MJ and Thurlbey PL (1996) Genomes, Molecular Biolology and Drug Discovery. Academic Press Ltd: London
15. Bukanov NO, Demidov VV, Nielsen PF and Frankkamenetskii MD (1998) PD-loop: a complex of duplex DNA with an oligonucleotide. Proc Natl Acad Sci USA 95: 5516-5520
16. Chiang SY, Azizkhan JC and Beerman TA (1998) A comparison of DNA-binding drugs as inhibitors of E12F1 and Sp1 DNA complexes and associated gene expression. Biochemistry 37: 3109-3115
17. Choo Y and Klug A (1994a) Selection of DNA-binding sites for zinc fingers using rationally randomized DNA reveals coded interactions. Proc Natl Acad Sci USA 91: 11168-11172
18. Choo Y and Klug A (1994b) Toward a code for the interactions of zinc fingers with DNA selection of randomized fingers displayed on phage. Proc Natl Acad Sci USA 91: 11163-11167
19. Choo Y, Sanchezgarcia I and Klug A (1994) In-vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence. Nature 372: 642-645
20. Choo Y, Castellanos A, GarciaHernandez B, SanchezGarcia I and Klug A (1997) Promoter-specific activation of gene expression directed by bacteriophage-selected zinc fingers. J Mol Biol 273: 525-532
21. Christensen L, Fitzpatrick R, Gildea B, Petersen KH, Hansen MF, Koch T, Egholm M, Buchardt O, Nielsen PE, Coull J and Berg RH (1995) Solid phase synthesis of peptide nucleic acids. J Peptide Sci 1: 175-183
22. Demidov VV, Potaman VN, Frankkamenetskii MD, Egholm M, Buchard O, Sonnichsen SH and Nielsen PE (1994) Stability of peptide nucleic-acids in human serum and cellular-extracts. Biochem Pharmacol 48: 1310-1313
23. Dervan PB (1997) Gene-specific transcription inhibition in vivo by designed ligands. Faseb J II: 2546
24. Dickinson LA, Gulizia RJ, Trauger JW, Baird EE, Mosier DE, Gottesfeld JM and Dervan PB (1998) Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands. Proc Natl Acad Sci USA 95: 12890-12895
25. Egholm M, Buchardt O, Christensen L, Behrens C, Freier SM, Driver DA, Berg RH, Kim SK, Norden B and Nielsen PE (1993) PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen bonding rules. Nature 365: 566-568
26. Eldrup AB, Dahl O and Nielsen PE (1997) A novel peptide nucleic acid monomer for recognition of thymine in triple-helix structures. J Am Chem Soc 119: 11116-11117
27. Ellington AD and Szostak JW (1990) Invitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822
28. Elstein KH and Zucker RM (1994) Comparison of cellular and nuclear-flow cytometric techniques for discriminating apoptolic subpopulations. Exp Cell Res 211: 322-331
29. Eriksson M and Nielsen PE (1996) PNA nucleic acid complexes. Structure, stability and dynamics. Quart Rev Biophys 29: 369-394
30. Escude C, Francois JC, Sun JS, Ott G, Sprinzl M, Garestier T and Helene C (1993) Stability of triple helices containing RNA and DNA strands: experimental and molecular modeling studies. Nucleic Acids Res 21: 5547-5553
31. Escude C, Nguyen CH, Kukreti S, Janin Y, Sun JS, Bisagni E, Garestier T and Helene C (1998) Rational design of a triple helix-specific intercalating ligand. Proc Natl Acad Sci USA 95: 3591-3396
32. Espinas ML, JimenezGarcia E, MartinezBalbas A and Azorin F (1996) Formation of triple-stranded DNA at d(GA center dot TC)(n) sequences prevents nucleosome assembly and is hindered by nucleosomes. J Biol Chem 271: 31807-31812
33. Farmer JD, Rudnicki SM and Suggs JW (1998) Synthesis and DNA crosslinking ability of a dimeric anthramycin analog. Tetrahedron Lett 29: 5105-5108
34. Farmer JD, Gustafson GR, Conti A, Zimmt MB and Suggs JW (1991) DNA-binding properties of a new class of linked anthramycin analogs. Nucleic Acids Res 19: 899-903
35. Fell P, Hudson AJ, Reynolds M, Usman N and Akhtar S (1997) Cellular uptake properties of 2′-amino/ 2′-O-methyl-modified hammerhead ribozymes targeted to the epidermal growth factor receptor mRNA. Antisense Nucleic Acid Drug Dev 7: 319-326
36. Filatov MV and Varfolomeeva EY (1995) Active dissociation of Hoechst-33342 from DNA in living mammalian cells. Mutation Res Fund Mol Mech Mutagen 327: 209-215
37. Fossella JA, Kim YJ, Shih H, Richards EG and Fresco JR (1903) Relative specificities in binding of Watson Crick base-pairs by 3rd strand residues in a DNA pyrimidine triplex motif. Nucleic Acids Res 21: 4511-4515
38. Gilar M, Relenky A, Smisek DL, Bourque A and Cohen AS (1997) Kinetics of phosphorothioate oligonucleotide metabolism in biological fluids. Nucleic Acids Res 25: 3615-3620
39. Giovannangeli C, Diviacco S, Labrousse V, Gryaznov S, Charneau P and Helene C (1997) Accessibility of nuclear DNA to triplex-forming oligonucleotides: the integrated HIV-1 provirus as a target. Proc Natl Acad Sci USA 94: 79-84
40. Good L and Nielsen PE (1997) Progress in developing PNA as a gene-targeted drug, Antisense & Nucleic Acid Drug Dev 7: 431-437
41. Gossen M and Bujard H (1992) Tight control of gene-expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89: 5547-5551
42. Gottesfeld JM, Neely L, Trauger JW, Baird EE and Dervan PB (1997) Regulation of gene expression by small molecules. Nature 387: 202-205
43. Griffin LC and Dervan PB (1989) Recognition of thymine: adenine base-pairs by guanine in a pyrimidine triple helix motif. Science 245: 967-971
44. Grootenhuis PDJ, Roe DC, Kollman PA and Kuntz ID (1994) Finding potenlial DNA-binding compounds by using molecular shape. J Computer-Aided Mol Design 8: 731-750
45. Helene C (1998) DNA recognition: reading the minor groove. Nature 391: 436-438
46. Hermann T and Westhof E (1998) RNA as a drug target: chemical, modelling, and evolutionary tools. Curr Opin Biotechnol 9: 66-73
47. Herman DM, Baird EE and Dervan PB (1998) Stereochemical control of the DNA binding affinity, sequence specificity, and orientation preference of chiral hairpin polyamides in the minor groove. J Am Chem Soc 120: 1382-1391
48. Hertzberg RP, Hecht SM, Reynolds VL, Molineux IJ and Hurley LH (1986) DNA-sequence specificity of the pyrrolo[1,4]benzodiazepine antitumor antibiotics: methidiumpropyl-EDTA-iron(II) footprinting analysis of DNA-binding sites for anthramycin and related drugs. Biochemistry 25: 1249-1258
49. Ho SP, Brilton DHO, Stone BA, Behrens DL, Leffet LM, Hobbs FW, Miller JA and Trainor GL (1996) Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries. Nucleic Acids Res 24: 1901-1907
50. Hurley LH, Reck T, Thurston DE, Langley DR, Holden KG, Hertzberg RP, Hoover JRF, Gallagher G Jnr, Faucette LF, Mong SM and Johnson RK (1988) Pyrrolo[I,4]benzodiazepine anlitumor antibiotics: relationship of DNA alkyhition and sequence specificity to the biological activity of natural and synthetic compounds. Chem Res Toxicol 1: 258-268
51. Isalan M, Choo Y and Klug A (1997) Synergy between adjacent zinc fingers in sequence-specific DNA recognition. Proc Natl Acad Sci USA 94: 5617-5621
52. Isalan M, Klug A and Choo Y (1998) Comprehensive DNA recognition through concerted interactions from adjacent zinc fingers. Biochemistry 37: 12026-12033
53. Jenkins TC, Hurley LH, Neidle S and Thurston DE (1994) Structure of a covalent DNA minor groove adduct with a pyrrolobenzodiazepine dimer: evidence for sequence-specific interstrand cross-linking. J Med Chem 37: 4529-1537
54. Jones KA and Peterlin BM (1994) Control of RNA initiation and elongation at the HIV-1 promoter. Ann Rev Biochem 63 717-743
55. Kielkopf CL, Baird EE, Dervan PD and Rees DC (1998a) Structural basis for G center dot C recognition in the DNA minor groove. Nat Struct Biol 5: 104-109
56. Kielkopf CL, White S, Szewczyk JW, Turner JM, Baird EE, Dervan PB and Rees DC (1998b) A structural basis for recognition of A center dot T and T center dot A base pairs in the minor groove of B-DNA. Science 282: 111-115
57. Koshlap KM, Gillespie P, Denvan PB and Fergon J (1993) Nonnatural deoxyribonucleoside-D(3) incorporated in an intramolecular DNA triplex binds sequence-specifically by interealation. J Am Chem Soc 115: 7908-7909
58. Kukreti S, Sun JS, Garestier T and Helene C (1997) Extension of the range of DNA sequences available for triple helix formation: stabilisation of mismatched triplexes by acridine-containing oligonucleotides. Nucleic Acids Res 25: 4264-1270
59. Leimgruber W, Stefanovic V, Shenker F, Karr A and Berger J (1965) Isolation and characterization of anthramycin, a new antitumour antibiotic. J Am Chem Soc 87: 5791-5793
60. Lescrinier T, Hendrix C, Kerremans L, Rozenski J, Link A, Samyn P, VanAerschot A, Lescrinier E, Eritja R, VanBeeumen J and Herdewijn P (1998) DNA-binding ligands from peptide libraries containing unnatural amino acids. Chem Eur J 4: 425-433
61. Lewis KJ, Irwin WJ and Akhtar S (1998) Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro. J Drug Target 5: 291-302
62. Liu C, Smith BM, Ajito K, Komatsu H, GomezPaloma L, Li TH, Theodorakis EA, Nicolaou KC and Vogt PK (1996) Sequence-selective carbohydrate DNA interaction: dimeric and monomeric forms of the calicheamicin oligosaccharide interfere with transcription factor function. Proc Natl Acad Sci USA 93: 940-944
63. Lown JW (1995) Design acid development of sequence selective lexitropsin DNA minor groove binders. Drug Dev Res 34: 145-183
64. Macdonald F and Ford CHJ (1997) Molecular Biology of Cancer. BIOS Scientific Publishers Ltd.
65. McGrovren JP, Lee CS, Hurley LH, Li LH and Kelly RC (1987) DNA-bindnlg and biological-activity of the cyclopropyl enantiomer of the antitumor antibiotic CC-1065. Proc Am Assoc Cancer Res 28: 262
66. Majumdar A, Khorlin A, Dyalkina N, Lin FLM, Powell J, Liu J, Feiz ZZ, Khripine Y, Watanabe KA, George J, Glazer PM and Seidman MM (1998) Targeted gene knockout mediated by triple helix forming oligonucleotides. Nat Genet 20: 212-214
67. Matteucci MD and Wagner RW (1996) In pursuit of antisense. Nature 384: 20-22
68. Mercola D and Cohen JS (1995) Antisense approaches to cancer gene-therapy. Cancer Gene Theraphy 2: 47-59
69. Michael K and Tor Y (1998) Designing novel KNA binders. Chem Eur J 4: 2091-2098
70. Milner N, Mir KU and Southern EM (1997) Selecting effective antisense reagents on combinatorial oligonucleotide arrays. Nature Biotechnol 15: 537-541
71. Mologni L, leCoutre P, Nielsen PE and GambacortiPasserini C (1998) Additive antisense effects of different PNAs on the in vitro translation of the PML/RAR alpha gene. Nucleic Acids Res 26: 1934-1938
72. Monia BP (1997) First-and second-generation antisense inhibitors targeted to human c-rafkinase: in vitro and in vivo studies. Anti-Cancer Drug Design 12: 327-339
73. Monia BP, Johnston JF, Geiger T, Muller M and Fabbro D (1996a) Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat Med 2: 668-675
74. Monia BP, Sasmor H, Johnston JF, Freier SM, Lesnik EA, Muller M, Geiger T, Altmann KH, Moser H and Fabbro D (1996b) Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-rafkinase supports an antisense mechanism of action in vivo. Proc Natl Acad Sci USA 93: 15481-15484
75. Mountzouris JA, Wang JJ, Thurston DE and Hurley LH (1994) Comparison of a DSB-120 DNA interstrand cross-linked adduct with the corresponding bis-tomaymycin adduct: an example of a successful template-directed approach to drug design based upon the monoalkylating compound tomaymycin. J Med Chem 37: 3132-3140
76. Mrksieh M, Wade WS, Dwyer TJ, Geierstanger BH, Wemmer DE and Dervan PB (1992) Antiparallel side-by-side dimeric motil for sequence-specific recognition in the minor groove of DNA by the designed peptide 1-methylimidazole-2-carboxamide netropsin. Proc Natl Acad Sci USA 89: 7586-7590
77. Mrksieh M, Parks ME and Dervan PB (1994) Hairpin peptide motif: a new class of oligopeptides for sequence-specific recognition in the minor-groove of double-helical DNA. J Am Chem Soc 116: 7983-7988
78. Neidle S (1997) Recent developments in triple-helix regulation of gene expression. Anticancer Drug Design 12: 433-442
79. Neidle S and Thurston DE (1994) DNA sequences as targets for new anticancer agents. In: New Targets for Cancer Chemotherapy. Kerr DJ and Workman P (eds), pp. 159-175. Boca Raton, Florida: CRC Press Ltd.
80. Neidle S, Puvvada MS and Thurston DE (1994) The relevance of drug-DNA sequence specificity to antitumor activity. Eur J Cancer 30A: 567-568
81. Nielsen PE, Egholm M, Berg RH and Buchardt O (1991) Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254: 1497-1500
82. No D, Yao TP and Evans RM (1996) Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 93: 3346-3351
83. Park HJ, Kelly RC and Hurley LH (1996) The chemical evolution of DNA-DNA interstrand cross-linkers that recognize defined mixed AT and GC sequences. J Am Chem Soc 118: 10041-10051
84. Pelton JG and Wemmer DE (1989) Structural characterization of a 2-1 distamycin a.D (CGCAAATTGGC) complex by two-dimensional NMR. Proc Natl Acad Sci USA 86: 5723-5727
85. Phylactou LA, Kilpatrick MW and Wood MJA (1998) Ribozymes as therapeutic look for genetic disease. Hum Mol Genet 7: 1649-1653
86. Povsic TJ and Dervan PB (1989) Triple helix formation by oligonucleotides on DNA extended to the physiological pH range. J Am Chem Soc 111: 3059-3061
87. Puvvada MS, Hartley JA, Jenkins TC and Thurston DE (1993) A quantitative assay to measure the relative DNA-binding affinity of pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumor antibiotics based on the inhibition of restriction endonuclease [BamH 1]. Nucleic Acids Res 21: 3671-3675
88. Puvvada MS, Forrow SA, Hartley JA, Stephenson P, Gibson I, Jenkins TC and Thurston DE (1997) Inhibition of bacteriophage T7 RNA polymerase in vitro transcription by DNA-binding pyrrolo[2,1-c][1,4]benzodiazepines. Biochemistry 36: 2478-2484
89. Rayson D, Pilot HC, Reid JM, Ames MM, Bagniewski PG, Erlichman C, Sloan JA and Adjei AA (1998) A phase I study of bizelesin (NSC 615291) in solid tumors. Ann Oncol 9: 475
90. Rossiter BJE, Fuscoe JC, Muzny DM, Fox M and Caskey CT (1991) The Chinese Hamster Hprt gene: restriction map, sequence-analysis, and multiplex PCR deletion screen. Genomics 9: 247-256
91. Shamdas GJ, Alberts DS, Modiano M, Wiggins C, Power J, Kasunic DA, Elfring GL and Earhart RH (1994) Phase I study of adozelesin (U-73,975) in patients with solid tumors. Anticancer Drugs 5: 10-14
92. Sidransky D (1997) Nucleic acid-based methods for the detection of cancer. Science 278: 1054-1058
93. Smellie M, Kelland LR, Thurston DE, Souhami RL and Hartley JA (1994) Cellular pharmacology of novel C8-linked anthramycin-based sequence-selective DNA minor groove cross linking agents. Br J Cancer 70: 48-53
94. Southern EM (1997) In: Oligonucleotides as Therapeutic Agents, Chadwick D and Cardew G (eds). J. Wiley & Sons: Chichester
95. Southern EM, Casegreen SC, Elder JK, Johnson M, Mir KU, Wang L and Williams JC (1994) Arrays of complementary oligonucleotides for analyzing the hybridization behavior of nucleic acids. Nucleic Acids Res 22: 1368-1373
96. Spencer DM, Wandless TJ, Schreiber SL and Crabtree GR (1993) Controlling signal-transduction with synthetic ligands. Science 262: 1019-1024
97. Strobel SA, Doucettestamm LA, Riba L, Housman DE and Dervan PB (1991) Site-specific cleavage of human chromosome-4 mediated by triple helix formation. Science 254: 1639-1642
98. Szewczyk JW, Baird EE and Dervan PB (1996) Sequence specific recognition of DNA by a major and minor groove binding ligand. Angewandte Chem 35: 1487-1489
99. Thuong NT and Helene C (1993) Sequence-specific recognition and modification of double-helical DNA by oligonucleotides. Angewandte Chem 32: 666-690
100. Thurston DE (1993) Advances in the study of pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumour antibiotics. In: Molecular Aspects of Anticancer Drug DNA Interactions, vol. I, Neidle S and Waring MJ (eds), pp. 54-88. Macmillan Press: London
101. Thurston DE and Bose DS (1994) Synthesis of DNA-interactive pyrrolo[2,1-c][1,4]benzodiazepines. Chem Rev 94: 433-465
102. Thurston DE, Bose DS, Thompson AS, Howard PW, Leoni A, Croker SJ, Jenkins TC, Neidle S, Hartley JA and Hurley LH (1996) Synthesis of sequence-selective C8-linked pyrrolo[2,1-c][1,4]benzodiazepine DNA interstrand cross-linking agents. J Organ Chem 61: 8141-8147
103. Trauger JW, Baird EE and Dervan PB (1996) Recognition of DNA by designed ligands at subnanomolar concentrations. Nature 382: 559-561
104. Trauger JW, Baird EE and Dervan PB (1998) Recognition of 16 base pairs in the minor groove of DNA by a pyrrole-imidazole polyamide dimer. J Am Chem Soc 120: 3534-3535
105. Turner JM, Baird EE and Dervan PB (1997) Recognition of seven base pair sequences in the minor groove of DNA by ten ring pyrrole-imidazole polyamide hairpins. J Am Chem Soc 119: 7636-7644
106. Uhlmann E (1998) Peptide nucleic acids (PNA) and PNA-DNA chimeras: from high binding affinity towards biological function. Biol Chem 379: 1045-1052
107. Wallis MG and Schroeder R (1997) The binding of antibiotics to RNA, Prog Biophys Mol Biol 67: 141-154
108. Wang G, Levy DD, Seidman MM and Glazer PM (1995) Targeted mutagenests in mammalian cells mediated by intracellular triple-helix formation. Mol Cell Biol 15: 1759-1768
109. Wemmer DE and Dervan PB (1997) Targeting the minor groove of DNA. Curr Opin Struct Biol 7: 355-361
110. Werstuck G and Green MR (1998) Controlling gene expression in living cells through small molecule RNA interactions. Science 282: 296-298
111. White S, Baird EE and Dervan PB (1997) On the pairing rules for recognition in the minor groove of DNA by pyrrole-imidazole polyamides. Chem Biol 4: 569-577
112. White S, Szewczyk JW, Turner JM, Baird EE and Dervan PB (1998) Recognition of the four Watson Crick base pairs in the DNA minor groove by synthetic ligands. Nature 391: 468-471
113. Wilson C and Szostak JW (1998) Isolation of a fluorophore-specific DNA aptamer with weak redox activity. Chem Biol 5: 609-617
114. Wong CH, Hendrix M, Manning DD, Rosenbohm C and Greenherg WA (1998) A library approach to the discovery of small molecules that recognize RNA: use of a 1,3-hydroxyamine motif as cure. J Am Chem Soc 120: 8319-8327